MX2007005153A - Uso de un inhibidor del mtor en el tratamiento de leiomioma del utero. - Google Patents
Uso de un inhibidor del mtor en el tratamiento de leiomioma del utero.Info
- Publication number
- MX2007005153A MX2007005153A MX2007005153A MX2007005153A MX2007005153A MX 2007005153 A MX2007005153 A MX 2007005153A MX 2007005153 A MX2007005153 A MX 2007005153A MX 2007005153 A MX2007005153 A MX 2007005153A MX 2007005153 A MX2007005153 A MX 2007005153A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- mtor inhibitor
- uterine leiomyoma
- leiomyoma
- uterine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
La invencion proporciona el uso de un inhibidor del mTOR en el tratamiento o la inhibicion de fibroides.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62291704P | 2004-10-28 | 2004-10-28 | |
PCT/US2005/039836 WO2006050461A1 (en) | 2004-10-28 | 2005-10-21 | Use of an mtor inhibitor in treatment of uterine leiomyoma |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007005153A true MX2007005153A (es) | 2007-06-26 |
Family
ID=35768583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007005153A MX2007005153A (es) | 2004-10-28 | 2005-10-21 | Uso de un inhibidor del mtor en el tratamiento de leiomioma del utero. |
Country Status (17)
Country | Link |
---|---|
US (1) | US7528145B2 (es) |
EP (1) | EP1804779A1 (es) |
JP (1) | JP2008518966A (es) |
KR (1) | KR20070070184A (es) |
CN (1) | CN101048152A (es) |
AU (1) | AU2005302004A1 (es) |
BR (1) | BRPI0518079A (es) |
CA (1) | CA2585840A1 (es) |
CR (1) | CR9068A (es) |
EC (1) | ECSP077426A (es) |
IL (1) | IL182748A0 (es) |
MX (1) | MX2007005153A (es) |
NI (1) | NI200700111A (es) |
NO (1) | NO20071926L (es) |
RU (1) | RU2007112787A (es) |
WO (1) | WO2006050461A1 (es) |
ZA (1) | ZA200703446B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2485841T3 (es) | 2002-02-01 | 2014-08-14 | Ariad Pharmaceuticals, Inc | Compuestos que contienen fósforo y usos de los mismos |
CA2669415A1 (en) * | 2006-11-14 | 2008-05-22 | Ariad Pharmaceuticals, Inc. | Solid dosage form comprising ap23573 |
US8425459B2 (en) | 2006-11-20 | 2013-04-23 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent |
US9700704B2 (en) | 2006-11-20 | 2017-07-11 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
US8998846B2 (en) | 2006-11-20 | 2015-04-07 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
US20080276935A1 (en) | 2006-11-20 | 2008-11-13 | Lixiao Wang | Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
US20080175887A1 (en) | 2006-11-20 | 2008-07-24 | Lixiao Wang | Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs |
US8414525B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US9737640B2 (en) | 2006-11-20 | 2017-08-22 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US8414910B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US8414526B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids |
JP2008305262A (ja) * | 2007-06-08 | 2008-12-18 | Konica Minolta Business Technologies Inc | サーバ及びシンクライアント環境でのプリンタ紹介方法 |
WO2009131631A1 (en) * | 2008-04-14 | 2009-10-29 | Poniard Pharmaceuticals, Inc. | Rapamycin analogs as anti-cancer agents |
WO2010024898A2 (en) | 2008-08-29 | 2010-03-04 | Lutonix, Inc. | Methods and apparatuses for coating balloon catheters |
WO2010118419A2 (en) * | 2009-04-10 | 2010-10-14 | Haiyan Qi | Novel anti-aging agents and methods to identify them |
AU2012320465B2 (en) * | 2011-10-07 | 2016-03-03 | Cellzome Limited | Morpholino substituted bicyclic pyrimidine urea or carbamate derivatives as mTOR inhibitors |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4316885A (en) | 1980-08-25 | 1982-02-23 | Ayerst, Mckenna And Harrison, Inc. | Acyl derivatives of rapamycin |
US4650803A (en) | 1985-12-06 | 1987-03-17 | University Of Kansas | Prodrugs of rapamycin |
US5023264A (en) | 1990-07-16 | 1991-06-11 | American Home Products Corporation | Rapamycin oximes |
US5023263A (en) | 1990-08-09 | 1991-06-11 | American Home Products Corporation | 42-oxorapamycin |
US5023262A (en) * | 1990-08-14 | 1991-06-11 | American Home Products Corporation | Hydrogenated rapamycin derivatives |
US5221670A (en) | 1990-09-19 | 1993-06-22 | American Home Products Corporation | Rapamycin esters |
US5233036A (en) | 1990-10-16 | 1993-08-03 | American Home Products Corporation | Rapamycin alkoxyesters |
US5120842A (en) | 1991-04-01 | 1992-06-09 | American Home Products Corporation | Silyl ethers of rapamycin |
US5100883A (en) | 1991-04-08 | 1992-03-31 | American Home Products Corporation | Fluorinated esters of rapamycin |
US5118678A (en) | 1991-04-17 | 1992-06-02 | American Home Products Corporation | Carbamates of rapamycin |
US5118677A (en) | 1991-05-20 | 1992-06-02 | American Home Products Corporation | Amide esters of rapamycin |
US5162333A (en) | 1991-09-11 | 1992-11-10 | American Home Products Corporation | Aminodiesters of rapamycin |
US5177203A (en) | 1992-03-05 | 1993-01-05 | American Home Products Corporation | Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents |
US5256790A (en) | 1992-08-13 | 1993-10-26 | American Home Products Corporation | 27-hydroxyrapamycin and derivatives thereof |
GB9221220D0 (en) | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
US5480988A (en) | 1992-10-13 | 1996-01-02 | American Home Products Corporation | Carbamates of rapamycin |
US5411967A (en) | 1992-10-13 | 1995-05-02 | American Home Products Corporation | Carbamates of rapamycin |
US5480989A (en) | 1992-10-13 | 1996-01-02 | American Home Products Corporation | Carbamates of rapamycin |
US5434260A (en) | 1992-10-13 | 1995-07-18 | American Home Products Corporation | Carbamates of rapamycin |
US5489680A (en) | 1992-10-13 | 1996-02-06 | American Home Products Corporation | Carbamates of rapamycin |
US5302584A (en) | 1992-10-13 | 1994-04-12 | American Home Products Corporation | Carbamates of rapamycin |
US5262423A (en) | 1992-10-29 | 1993-11-16 | American Home Products Corporation | Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents |
US5260300A (en) | 1992-11-19 | 1993-11-09 | American Home Products Corporation | Rapamycin carbonate esters as immuno-suppressant agents |
US5504091A (en) | 1993-04-23 | 1996-04-02 | American Home Products Corporation | Biotin esters of rapamycin |
US5536729A (en) | 1993-09-30 | 1996-07-16 | American Home Products Corporation | Rapamycin formulations for oral administration |
US5378836A (en) | 1993-10-08 | 1995-01-03 | American Home Products Corporation | Rapamycin oximes and hydrazones |
US5391730A (en) | 1993-10-08 | 1995-02-21 | American Home Products Corporation | Phosphorylcarbamates of rapamycin and oxime derivatives thereof |
US5373014A (en) | 1993-10-08 | 1994-12-13 | American Home Products Corporation | Rapamycin oximes |
US5385908A (en) | 1993-11-22 | 1995-01-31 | American Home Products Corporation | Hindered esters of rapamycin |
US5385910A (en) | 1993-11-22 | 1995-01-31 | American Home Products Corporation | Gem-distributed esters of rapamycin |
US5385909A (en) | 1993-11-22 | 1995-01-31 | American Home Products Corporation | Heterocyclic esters of rapamycin |
US5389639A (en) | 1993-12-29 | 1995-02-14 | American Home Products Company | Amino alkanoic esters of rapamycin |
US5362718A (en) | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
US5463048A (en) | 1994-06-14 | 1995-10-31 | American Home Products Corporation | Rapamycin amidino carbamates |
US5491231A (en) | 1994-11-28 | 1996-02-13 | American Home Products Corporation | Hindered N-oxide esters of rapamycin |
US5665591A (en) * | 1994-12-06 | 1997-09-09 | Trustees Of Boston University | Regulation of smooth muscle cell proliferation |
US5563145A (en) | 1994-12-07 | 1996-10-08 | American Home Products Corporation | Rapamycin 42-oximes and hydroxylamines |
WO1997017091A1 (en) | 1995-11-08 | 1997-05-15 | University Of South Florida | Guinea pig model for leiomyomas and atherosclerosis |
US5780462A (en) | 1995-12-27 | 1998-07-14 | American Home Products Corporation | Water soluble rapamycin esters |
WO1998002441A2 (en) | 1996-07-12 | 1998-01-22 | Ariad Pharmaceuticals, Inc. | Non immunosuppressive antifungal rapalogs |
US5989591A (en) | 1997-03-14 | 1999-11-23 | American Home Products Corporation | Rapamycin formulations for oral administration |
AU8282798A (en) | 1997-07-01 | 1999-01-25 | Atherogenics, Inc. | Antioxidant enhancement of therapy for hyperproliferative conditions |
US6015815A (en) * | 1997-09-26 | 2000-01-18 | Abbott Laboratories | Tetrazole-containing rapamycin analogs with shortened half-lives |
TW557297B (en) | 1997-09-26 | 2003-10-11 | Abbott Lab | Rapamycin analogs having immunomodulatory activity, and pharmaceutical compositions containing same |
JP2000012799A (ja) * | 1998-06-25 | 2000-01-14 | Nec Ic Microcomput Syst Ltd | 半導体メモリ装置とその製造方法 |
ES2219388T3 (es) | 1999-08-24 | 2004-12-01 | Ariad Gene Therapeutics, Inc. | 28-epi-rapalogos. |
US6277983B1 (en) * | 2000-09-27 | 2001-08-21 | American Home Products Corporation | Regioselective synthesis of rapamycin derivatives |
JP2004507465A (ja) * | 2000-08-11 | 2004-03-11 | ワイス | エストロゲン受容体陽性癌腫の治療方法 |
UA77200C2 (en) * | 2001-08-07 | 2006-11-15 | Wyeth Corp | Antineoplastic combination of cci-779 and bkb-569 |
US20030144204A1 (en) | 2001-12-19 | 2003-07-31 | Baylor College Of Medicine | Akt-based inducible survival switch |
JP2005537285A (ja) | 2002-07-30 | 2005-12-08 | ワイス | ラパマイシンヒドロキシエステルを含有する非経口製剤 |
RU2005106855A (ru) * | 2002-08-12 | 2005-10-10 | Дзе Риджентс оф дзе Юниверсити оф Мичиган (US) | Диагностика и лечение заболеваний, вызываемых дефектами каскада реакций, обусловливающих туберозный склероз |
BR0314397A (pt) | 2002-09-17 | 2005-08-09 | Wyeth Corp | Formulações orais |
UA83484C2 (uk) * | 2003-03-05 | 2008-07-25 | Уайт | Спосіб лікування раку грудей комбінацією похідного рапаміцину і інгібітора ароматази - летрозолу, фармацевтична композиція |
AR043504A1 (es) * | 2003-03-17 | 2005-08-03 | Novartis Ag | Composiciones farmaceuticas que comprenden rapamicina para el tratamiento de enfermedades inflamatorias |
ATE365169T1 (de) | 2003-08-07 | 2007-07-15 | Wyeth Corp | Regioselektive synthese von cci-779 |
-
2005
- 2005-10-21 CN CNA200580036444XA patent/CN101048152A/zh active Pending
- 2005-10-21 JP JP2007539341A patent/JP2008518966A/ja active Pending
- 2005-10-21 KR KR1020077009411A patent/KR20070070184A/ko not_active Application Discontinuation
- 2005-10-21 BR BRPI0518079-1A patent/BRPI0518079A/pt not_active IP Right Cessation
- 2005-10-21 EP EP05818897A patent/EP1804779A1/en not_active Withdrawn
- 2005-10-21 RU RU2007112787/15A patent/RU2007112787A/ru not_active Application Discontinuation
- 2005-10-21 US US11/255,267 patent/US7528145B2/en not_active Expired - Fee Related
- 2005-10-21 AU AU2005302004A patent/AU2005302004A1/en not_active Abandoned
- 2005-10-21 MX MX2007005153A patent/MX2007005153A/es not_active Application Discontinuation
- 2005-10-21 CA CA002585840A patent/CA2585840A1/en not_active Abandoned
- 2005-10-21 WO PCT/US2005/039836 patent/WO2006050461A1/en active Application Filing
-
2007
- 2007-04-16 NO NO20071926A patent/NO20071926L/no not_active Application Discontinuation
- 2007-04-19 CR CR9068A patent/CR9068A/es not_active Application Discontinuation
- 2007-04-23 IL IL182748A patent/IL182748A0/en unknown
- 2007-04-26 ZA ZA200703446A patent/ZA200703446B/xx unknown
- 2007-04-27 NI NI200700111A patent/NI200700111A/es unknown
- 2007-04-27 EC EC2007007426A patent/ECSP077426A/es unknown
Also Published As
Publication number | Publication date |
---|---|
RU2007112787A (ru) | 2008-12-10 |
BRPI0518079A (pt) | 2008-11-04 |
WO2006050461A1 (en) | 2006-05-11 |
ZA200703446B (en) | 2010-10-27 |
CA2585840A1 (en) | 2006-05-11 |
EP1804779A1 (en) | 2007-07-11 |
CN101048152A (zh) | 2007-10-03 |
US20060094745A1 (en) | 2006-05-04 |
KR20070070184A (ko) | 2007-07-03 |
JP2008518966A (ja) | 2008-06-05 |
US7528145B2 (en) | 2009-05-05 |
CR9068A (es) | 2007-10-01 |
IL182748A0 (en) | 2007-09-20 |
AU2005302004A1 (en) | 2006-05-11 |
ECSP077426A (es) | 2007-05-30 |
NI200700111A (es) | 2008-01-17 |
NO20071926L (no) | 2007-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007005153A (es) | Uso de un inhibidor del mtor en el tratamiento de leiomioma del utero. | |
ZA200507996B (en) | Use of an IBAT inhibitor for the treatment or prophylaxis of constipation | |
IL178125A0 (en) | Gsk-3 inhibitors | |
IL189659A0 (en) | Ikk inhibitors for the treatment of endometriosis | |
PT1761520E (pt) | Inibidores de quinase | |
ATE394077T1 (de) | Prolaps-reparatur | |
IL174014A0 (en) | Methods for the treatment of endometriosis | |
UA85505C2 (en) | Kinase inhibitors | |
EP2023874A4 (en) | METHOD FOR IDENTIFYING ACTIVE SUBSTANCES AND THEIR USE FOR THE PREVENTION OF RESTENOSIS | |
HK1112171A1 (en) | Device for cauterising tissue | |
TW200510398A (en) | Novel compounds | |
HK1100895A1 (zh) | 用於治療平足的外科裝置及對應的外科配套組件 | |
UA94049C2 (ru) | Применение ингибиторов glepp-1 для лечения аутоиммунных и/или воспалительных расстройств | |
MXPA05011699A (es) | Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior. | |
IL175372A0 (en) | Solid amorphous dispersions of an mtp inhibitor for treatment of obesity | |
EP1731529A4 (en) | INHIBITORS OF CALCIUM ION LEAKAGE | |
ZA200802080B (en) | P13K inhibitors for the treatment of endometriosis | |
AP2003002855A0 (en) | Inhibitor of monoamine uptake. | |
EP1776956A4 (en) | PREVENTIVE AND / OR THERAPEUTIC AGENT FOR CALCIPENIA | |
IL178907A0 (en) | Use of sulglicotide for the treatment of mucositis | |
EP1607102A4 (en) | PREVENTION OF ADHERENCE FOLLOWING ABDOMINAL SURGICAL INTERVENTION | |
GB2461615A (en) | Assay devices and methods and components for use therein | |
EP1804805A4 (en) | USE OF AROMATASE INHIBITORS FOR THE TREATMENT OF ECTOPIC PREGNANCY | |
GB2445882B (en) | Prophylactic and therapeutic agents and compositions and uses therefor and methods for determining the presence or severity of neuronal damage | |
ZA200800245B (en) | JNK inhibitors for the treatment of endometriosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |